MeSH tree: E02.095.465.425
George Washington had a problem in the winter of 1777. Smallpox was devastating the already undermanned Continental Army, and much-needed new recruits were being quarantined for a month as a precautionary measure. In addition, ...
Mar 18, 2026
0
9
Cancer-fighting T cells do not simply "run out of energy." They are molecularly reprogrammed. For years, mitochondrial dysfunction has been recognized as a hallmark of exhausted T cells in tumors. Yet how metabolic stress ...
Mar 18, 2026
0
11
Lymph nodes, considered the command centers of our immune system, often get swollen and stiff when fighting infection. Now, a UC Berkeley-led team of researchers has discovered that this mechanical change may help instruct ...
Mar 12, 2026
0
9
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it only appeared on the inside of cells, where it sent signals that fueled tumor growth and stayed hidden ...
Mar 12, 2026
0
25
A Simon Fraser University study is pushing back against the "easy narrative" that not getting vaccinated is entirely a personal decision. Rather, vaccine hesitancy in Canada comes down to significant cultural, administrative, ...
Mar 11, 2026
0
6
A new study has revealed a promising new approach to curb the spread of triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease. Published recently in Cancer Letters, Gabriel ...
Mar 10, 2026
0
21
Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T cells to target specific ...
Mar 9, 2026
0
9
If you live in parts of the West and South, you may already be reaching for your allergy meds.
Mar 7, 2026
0
9
In little moments like when sipping coffee or licking an ice cream cone, it doesn't seem like your body is pulling off a biological miracle. But it is. That cookie is not you—yet when you put it in your mouth, your body is ...
Mar 7, 2026
0
20
CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone lymphoma, according to a recent clinical trial published in The Lancet. Marginal zone lymphoma ...
Mar 4, 2026
0
6
